(Q40512932)

English

Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost

scientific article published on January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost (English)

1 reference

Europe PubMed Central

21 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Funda Corapçioglu

1

1 reference

Europe PubMed Central

21 September 2017

Nazan Sarper

2

1 reference

Europe PubMed Central

21 September 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

21 September 2017

Pediatric Hematology and Oncology

1 reference

Europe PubMed Central

21 September 2017

22

1 reference

Europe PubMed Central

21 September 2017

59-70

1 reference

Europe PubMed Central

21 September 2017

1

1 reference

Europe PubMed Central

21 September 2017

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Empirical antibiotic therapy in neutropenic cancer patients.

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Is monotherapy for febrile neutropenia still a viable alternative?

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Cefepime microbiologic profile and update

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Treatment of febrile neutropenia with cefepime monotherapy

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Immunohistology of lung cancer

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Treatment of febrile neutropenia: what is new?

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Modeling administrative outcomes in fever and neutropenia: clinical variables significantly influence length of stay and hospital charges

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Pharmacoeconomic analysis of empirical therapy with ceftazidime alone or combination antibiotics for febrile neutropenia in cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F08880010590896297

21 January 2018

Identifiers

10.1080/08880010590896297

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40512932&oldid=1899783834"